Tidal Vision is a biotechnology company specializing in sustainable chitosan-based solutions for industrial applications. Utilizing a proprietary zero-waste extraction process, the company eliminates the hazardous byproducts typically associated with traditional chitosan production. This eco-friendly approach minimizes environmental impact while significantly reducing production costs, enabling Tidal Vision to deliver the highest-quality chitosan at the most competitive price in the industry. By converting chitosan into ready-to-use, optimized formulas, Tidal Vision is driving innovation across water treatment, agriculture, textiles, and more.
Tidal Vision has raised $140 million in a Series B funding round. Investors included Cambridge Companies SPG, Eni Next, Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners’ Blue Ocean Fund, MBX Capital, Oman Investment Authority’s IDO Investments, and more.
Tidal Vision, Bellingham, Washington, United States, was founded in 2015 by Craig Kasberg and Zach Wilkinson. Tidal Vision operates across diverse markets, including water treatment, agriculture, textiles, industrial coatings, pulp and paper, and food industries, providing sustainable chitosan-based solutions tailored to each sector's needs. “We are thrilled to have these strategically aligned capital partners onboard and supportive of accelerating our mission," said Craig Kasberg, CEO of Tidal Vision. “We've already demonstrated it's possible to make our biomolecular solutions outcompete. Now, we're building infrastructure that'll allow us to better serve customers who operate in critical industries providing the clean water, agriculture production, and materials necessary for everyday life.”
Share this post